Symbol | Exchange | Currency |
|---|
MiMedx Group (MDXG) reported Q2 EPS of ($0.11), $0.05 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $66.88 million versus the consensus estimate of...
Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Oil & Gas, Financials and Telecoms sectors led shares higher while losses in the Healthcare,...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Monday, September 13th. Please refresh for updates.Apple (NASDAQ:AAPL) stock rose 1%, rebounding to a...
Investors in MiMedx Group, Inc. (NASDAQ:MDXG) need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 20th 2018 $17.50 Put...
Adamas Pharma (NASDAQ:ADMS) was up 1.72, or 5.35%, to 33.87, on 612,876 shares traded on Tuesday. What I’m seeing here is 4 waves up, and the 5th wave could take it to the...
Aerojet Rocketdyne Holdings Inc (NYSE:AJRD) was up 56 cents, or 2%, to 27.65, on 758,148 shares traded on Monday. It popped and pulled back, forming a nice wedge. I think it still...
MiMedx Group, Inc. is a transformational placental biologics company, developing and distributing placental tissue allografts for multiple sectors of healthcare. The Company is focused on addressing unmet clinical needs in the areas of advanced wound care, surgical recovery applications, and musculoskeletal conditions. The Company’s primary platform technologies include EPIFIX, AMNIOFIX, EPICORD, and AMNIOCORD. The AMNIOFIX and EPIFIX are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. Its EPICORD and AMNIOCORD are tissue allografts derived from umbilical cord tissue. EPIFIX is a semi-permeable, protective barrier allograft comprised of dehydrated human amnion/chorion membrane that may be used in the treatment of chronic wounds, including diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers. AMNIOFIX is used in surgical recovery applications including in the areas of spine, orthopedic, sports medicine and urologic.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Buy | Sell |
| Technical Indicators | Strong Buy | Sell | Strong Sell | Strong Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 65.22 | 65.35 | 64.71 | +0.34 | +0.52% | 6.49M | NYSE | |||
| 18.55 | 20.81 | 16.16 | -4.53 | -19.63% | 136.95M | NASDAQ | |||
| 367.99 | 369.94 | 362.75 | +3.30 | +0.90% | 1.96M | NYSE | |||
| 120.86 | 121.68 | 119.56 | +0.54 | +0.45% | 15.38M | NASDAQ | |||
| 245.17 | 246.48 | 239.28 | +4.02 | +1.67% | 5.27M | NASDAQ | |||
| 7.66 | 7.72 | 7.63 | +0.03 | +0.39% | 4.19M | NASDAQ | |||
| 53.55 | 53.72 | 53.04 | -0.21 | -0.39% | 10.31M | NYSE | |||
| 83.79 | 84.39 | 82.64 | +1.65 | +2.01% | 78.78K | NYSE | |||
| 173.05 | 175.14 | 171.58 | -2.29 | -1.31% | 4.23M | NYSE | |||
| 0.406 | 0.427 | 0.303 | +0.122 | +42.90% | 152.61M | NASDAQ | |||
| 266.58 | 267.36 | 265.42 | -0.24 | -0.09% | 1.59M | NYSE | |||
| 48.58 | 49.52 | 48.38 | -0.69 | -1.40% | 18.48M | NYSE | |||
| 68.14 | 68.16 | 67.63 | +0.45 | +0.66% | 215.05K | NYSE | |||
| 37.13 | 37.23 | 35.97 | +1.73 | +4.89% | 10.71M | NYSE | |||
| 94.02 | 99.91 | 93.22 | -10.40 | -9.96% | 5.16M | NYSE |